Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Br J Cancer ; 109(12): 3023-33, 2013 Dec 10.
Article in English | MEDLINE | ID: mdl-24220693

ABSTRACT

BACKGROUND: Radiotherapy can be an effective treatment for prostate cancer, but radiorecurrent tumours do develop. Considering prostate cancer heterogeneity, we hypothesised that primitive stem-like cells may constitute the radiation-resistant fraction. METHODS: Primary cultures were derived from patients undergoing resection for prostate cancer or benign prostatic hyperplasia. After short-term culture, three populations of cells were sorted, reflecting the prostate epithelial hierarchy, namely stem-like cells (SCs, α2ß1integrin(hi)/CD133(+)), transit-amplifying (TA, α2ß1integrin(hi)/CD133(-)) and committed basal (CB, α2ß1integrin(lo)) cells. Radiosensitivity was measured by colony-forming efficiency (CFE) and DNA damage by comet assay and DNA damage foci quantification. Immunofluorescence and flow cytometry were used to measure heterochromatin. The HDAC (histone deacetylase) inhibitor Trichostatin A was used as a radiosensitiser. RESULTS: Stem-like cells had increased CFE post irradiation compared with the more differentiated cells (TA and CB). The SC population sustained fewer lethal double-strand breaks than either TA or CB cells, which correlated with SCs being less proliferative and having increased levels of heterochromatin. Finally, treatment with an HDAC inhibitor sensitised the SCs to radiation. INTERPRETATION: Prostate SCs are more radioresistant than more differentiated cell populations. We suggest that the primitive cells survive radiation therapy and that pre-treatment with HDAC inhibitors may sensitise this resistant fraction.


Subject(s)
Histone Deacetylase Inhibitors/pharmacology , Hydroxamic Acids/pharmacology , Neoplastic Stem Cells/drug effects , Neoplastic Stem Cells/pathology , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/radiotherapy , Radiation-Sensitizing Agents/pharmacology , Aged , Aged, 80 and over , Cell Differentiation/drug effects , Cell Differentiation/radiation effects , Comet Assay , DNA Damage , Humans , Male , Middle Aged , Neoplastic Stem Cells/radiation effects , Prostatic Hyperplasia/pathology , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Tumor Cells, Cultured
2.
Avian Dis ; 27(3): 745-50, 1983.
Article in English | MEDLINE | ID: mdl-6639551

ABSTRACT

A neuraminidase-inhibition (NI) assay performed in microtiter plates is described. This micro-NI assay is a modification of the NI assay recommended by the World Health Organization. It reduces the quantity of reagents required and permits antigenic classification of many isolates simultaneously. To determine the accuracy and sensitivity of this micro-NI assay, 110 influenza A viruses, representing all subtypes, based upon the nine known neuraminidases (NAs), were classified by both the micro-NI and macro-NI assays in two separate laboratories. The NAs were identified accurately by the micro-NI assay. Virus mixtures were detected by both assays, although the macro-NI was clearly more sensitive. The micro-NI assay was also suitable for testing sera for the presence of antibodies to the NAs. Although the micro-NI assay did not provide the quantitation of the macro-NI assay, it did prove to be a rapid method for virus classification and antibody studies on influenza A viruses.


Subject(s)
Influenza A virus/classification , Neuraminidase/classification , Serotyping/veterinary , Animals , Antibodies, Viral/analysis , Antigens, Viral/analysis , Ducks/microbiology , Influenza A virus/isolation & purification , Serotyping/methods
3.
Cell Death Differ ; 21(5): 761-73, 2014 May.
Article in English | MEDLINE | ID: mdl-24464224

ABSTRACT

Prostate cancer (CaP) is mostly composed of luminal-like differentiated cells, but contains a small subpopulation of basal cells (including stem-like cells), which can proliferate and differentiate into luminal-like cells. In cancers, CpG island hypermethylation has been associated with gene downregulation, but the causal relationship between the two phenomena is still debated. Here we clarify the origin and function of CpG island hypermethylation in CaP, in the context of a cancer cell hierarchy and epithelial differentiation, by analysis of separated basal and luminal cells from cancers. For a set of genes (including GSTP1) that are hypermethylated in CaP, gene downregulation is the result of cell differentiation and is not cancer specific. Hypermethylation is however seen in more differentiated cancer cells and is promoted by hyperproliferation. These genes are maintained as actively expressed and methylation-free in undifferentiated CaP cells, and their hypermethylation is not essential for either tumour development or expansion. We present evidence for the causes and the dynamics of CpG island hypermethylation in CaP, showing that, for a specific set of genes, promoter methylation is downstream of gene downregulation and is not a driver of gene repression, while gene repression is a result of tissue-specific differentiation.


Subject(s)
DNA Methylation , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Animals , Cell Differentiation/genetics , Cell Growth Processes/genetics , Down-Regulation , Epithelial Cells/pathology , Heterografts , Humans , Male , Mice , Mice, Inbred BALB C , Prognosis , Tumor Cells, Cultured
4.
Oncogenesis ; 2: e45, 2013 Apr 15.
Article in English | MEDLINE | ID: mdl-23588494

ABSTRACT

The mouse haematopoietic stem cell (SC) regulator Latexin (LXN) is the only known homologue of the retinoic acid receptor responder 1 (RARRES1) gene. Both genes lie adjacent on chromosome 3 and differ mostly by the presence of a transmembrane domain in RARRES1. Despite their homology, it is not known whether they possess similar regulatory mechanisms, cellular localization and function. Here, we identified RARRES1 and LXN as highly significantly downregulated genes in human prostate SCs, whose expression was induced by the pro-differentiation agent all-trans retinoic acid (atRA). AtRA induced expression in the most differentiated cells compared with the SC fraction, suggesting that this subpopulation was less responsive to atRA. Small interfering RNA suppression of RARRES1 and LXN enhanced the SC properties of primary prostate cultures, as shown by a significant increase in their colony-forming ability. Expression of both RARRES1 and LXN was co-ordinately repressed by DNA methylation in prostate cancer cell lines and inhibition of RARRES1 and LXN increased the invasive capacity of primary prostate cultures, which also fully rescued an inhibitory effect induced by atRA. Moreover, we showed that RARRES1 and LXN reside within different sub-cellular compartments, providing evidence that RARRES1 is not a plasma membrane protein as previously supposed but is located primarily in the endoplasmic reticulum; whereas LXN was detected in the nucleus of prostate epithelial cells. Thus, LXN and RARRES1 are potential tumour suppressor genes, which are co-ordinately regulated, SC-silenced genes functioning to suppress invasion and colony-forming ability of prostate cancer cells; yet the proteins reside within different sub-cellular compartments.

5.
Oncogene ; 28(49): 4344-52, 2009 Dec 10.
Article in English | MEDLINE | ID: mdl-19784068

ABSTRACT

ApoJ/Clusterin (CLU) is a heterodimeric protein localized in the nucleus, cytoplasm or secretory organelles and involved in cell survival and neoplastic transformation. Its function in human cancer is still highly controversial. In this study, we examined the prostate of mice in which CLU has been genetically inactivated. Surprisingly, we observed transformation of the prostate epithelium in the majority of CLU knockout mice. Either PIN (prostate intraepithelial neoplasia) or differentiated carcinoma was observed in 100 and 87% of mice with homozygous or heterozygous deletion of CLU, respectively. Crossing CLU knockout with TRAMP (prostate cancer prone) mice results in a strong enhancement of metastatic spread. Finally, CLU depletion causes tumourigenesis in female TRAMP mice, which are normally cancer free. Mechanistically, deletion of CLU induces activation of nuclear factor-kB, a potentially oncogenic transcription factor important for the proliferation and survival of prostate cells.


Subject(s)
Carcinoma/pathology , Cell Transformation, Neoplastic/drug effects , Clusterin/antagonists & inhibitors , Clusterin/genetics , Prostatic Neoplasms/pathology , RNA, Small Interfering/pharmacology , Animals , Carcinoma/genetics , Cell Transformation, Neoplastic/genetics , Cells, Cultured , Female , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neoplasm Metastasis , Prostatic Intraepithelial Neoplasia/genetics , Prostatic Intraepithelial Neoplasia/pathology , Prostatic Neoplasms/genetics , RNA Interference/physiology
6.
Invest. clín ; 22(1): 43-52, 1981.
Article in Spanish | LILACS | ID: lil-6992

ABSTRACT

Se efectuo una comparacion antigenica entre 418 virus influenza A Hav6N2 aislados de muestras tomadas a patos salvajes del Canada en 1978, demostrandose, por las pruebas de inhibicion de la hemaglutinacion, que estos virus estan estrechamente relacionados ya que todos reaccionaron siguiendo un mismo patron; indicando asi que sus hemaglutinantes eran similares. Comparandolos con otros virus Hav6 los resultados IH demostraron que este grupo de virus aislados de patos pueden diferenciarse de otros virus Hav6 aislados de pavos y otros patos, evidenciandose asi que los cambios leves (drift) ocurren en los virus aviarios al igual que en los del hombre. La neuraminidasa de los virus Hav6N2 estudiados se relacionaba con la neuraminidasa de la cepa humana A Jap/305/57 (H2N2), evidenciando que antigenos de cepas humanas viejas continuan circulando entre las aves. Estos hallazgos indican que los virus aviarios pueden desempenar un papel importante en la ecologia de los virus influenza A, y al mismo tiempo intervenir en la aparicion de nuevos virus en otras especies de animales y del hombre


Subject(s)
Hemagglutination Inhibition Tests , Neuraminidase , Orthomyxoviridae
SELECTION OF CITATIONS
SEARCH DETAIL